vitro
interferon
product
peripher
blood
mononuclear
cell
children
suffer
recurr
upper
respiratori
tract
infect
examin
compar
healthi
children
five
respiratori
pathogen
virus
mycoplasma
pneumonia
use
induc
cell
everi
child
respond
least
three
six
induc
interferon
product
group
cultur
prepar
patient
cell
show
decreas
product
ifn
stimul
adeno
rhino
corona
rs
virus
mycoplasma
similar
trend
two
group
children
seen
regard
influenza
virusinduc
ifn
product
leukocyt
cultur
result
corrobor
previou
find
rel
defici
interferon
product
appear
inducerspecif
suggest
phenomenon
may
role
pathogenesi
recurr
respiratori
infect
prone
infect
children
clinic
import
problem
major
defect
immun
respons
may
bring
cycl
recur
infect
rare
demonstr
patient
certain
socioenvironment
factor
known
risk
factor
recur
respiratori
infect
unifi
biolog
caus
discov
situat
lyall
et
al
interferon
ifn
consid
major
factor
host
defenc
viru
infect
human
experiment
evid
point
import
ifn
system
among
host
resist
factor
effect
earli
phase
viral
infect
henc
limit
viru
spread
tissu
sever
studi
concern
disturb
ifn
product
variou
diseas
report
lsaac
et
al
first
describ
infectionpron
children
defici
virusinduc
ifn
product
author
could
reproduc
observ
children
year
later
children
longer
recurr
infect
suggest
genet
defici
reason
origin
low
ifn
yield
chadda
et
al
hand
sever
group
subsequ
report
leukocyt
proport
children
suffer
repeat
respiratori
infect
show
lower
product
interferon
bondestam
et
al
puglies
et
al
vanecek
et
al
studi
carri
use
singl
good
induc
viru
either
sendai
newcastl
diseas
viru
ndv
paramyxovirida
famili
previous
shown
ifn
yield
leukocyt
cultur
stimul
member
differ
viru
group
vari
depend
blood
donor
induc
viru
pitkiiranta
et
al
therefor
consid
worthwhil
reexamin
matter
use
batteri
natur
respiratori
pathogen
induc
interferon
product
test
leukocyt
cultur
children
repeat
respiratori
tract
infect
andor
frequent
middl
ear
infect
healthi
children
data
reveal
statist
signific
differ
ifn
yield
cultur
stimul
induc
studi
popul
compris
fifti
consecut
children
age
month
year
median
month
admit
mayaugust
schedul
oper
depart
otolaryngolog
univers
hospit
helsinki
undu
suscept
upper
respiratori
tract
infect
frequent
middl
ear
infect
inclus
criteria
compris
least
acut
otiti
episod
andor
least
episod
upper
respiratori
tract
infect
last
month
patient
enrol
studi
inform
consent
parent
histori
taken
routin
ear
nose
throat
examin
perform
usual
chain
infect
start
earli
age
month
year
median
month
children
healthi
least
one
week
sinc
last
infect
except
patient
ongo
mild
respiratori
tract
infect
four
addit
patient
longterm
prophylact
sulfisoxazol
treatment
week
month
recurr
infect
thirtynin
children
suffer
episod
upper
respiratori
tract
infect
rhiniti
pharyng
tonsil
occasion
combin
sinus
otiti
within
last
month
eleven
children
frequent
middl
ear
infect
without
associ
rhiniti
least
otiti
episod
within
last
month
present
visit
adenoidectomi
perform
patient
order
stop
chain
recurr
infect
ventil
tube
insert
patient
recurr
otiti
media
patient
reoper
readenoidectomi
andor
retympanostomia
continu
chain
upper
respiratori
tract
infect
spite
previou
intervent
blood
specimen
leukocyt
prepar
drawn
immedi
oper
use
needl
insert
inject
intraven
anaesthet
control
group
children
age
month
year
median
month
compris
children
particip
trial
assess
optim
time
schedul
regular
childhood
vaccin
show
clinic
symptom
diseas
also
previous
healthi
blood
leukocyt
prepar
drawn
mayjun
specimen
collect
trial
antibodi
assay
courtesi
j
eskola
pr
egggrown
influenza
viru
gift
r
pyhili
coronaviru
propag
human
embryon
cell
adenoviru
human
lung
cancer
cell
rhinoviru
strain
local
isol
ziegler
helaohio
cell
rsv
vero
cell
coronaviru
rsv
seed
gift
ziegler
aliquot
viru
stock
store
viru
tcidso
titr
measur
endpoint
dilut
tube
cultur
correspond
cell
mycoplasma
pneumonia
gift
r
riti
pellet
broth
cultur
homogen
sonic
suspend
pb
store
aliquot
leukocyt
heparin
blood
separ
ficolllsopaqu
gradient
describ
earlier
mononuclear
cell
interphas
gradient
collect
wash
time
phosphatebuff
salin
pb
adjust
concentr
x
tissu
cultur
medium
supplement
fetal
calf
serum
distrubut
aliquot
tissu
cultur
plate
well
cell
batch
freshli
made
parallel
leukocyt
cultur
inocul
within
h
collect
blood
sampl
crude
viru
mycoplasma
prepar
well
induc
singl
prepar
induc
use
throughout
studi
fresh
aliquot
thaw
experi
influenza
adenoand
rhinoviru
inocul
calcul
multipl
infect
moi
use
pitkiranta
et
al
titr
stock
coronaviru
rsv
low
moi
respect
use
mycoplasma
use
final
concentr
gml
capobianchi
et
al
plate
seal
adhes
tape
incub
cultur
medium
harvest
day
pitkiranta
et
al
clear
cell
centrifug
store
assay
pilot
experi
induc
select
dosag
induc
moder
level
ifn
leukocyt
cultur
healthi
blood
donor
ifn
concentr
measur
micromethod
base
reduct
cytopath
effect
caus
vesicular
stomati
viru
linnavuori
continu
bovin
cell
line
use
biolog
ifn
assay
sampl
patient
control
cultur
analyz
blindli
calibr
leukocyt
ifn
standard
gift
k
cantel
includ
assay
result
could
given
intern
unit
iu
result
given
mean
parallel
cultur
maximum
differ
seen
parallel
specimen
subtyp
ifn
specif
assess
studi
virusinduc
leukocyt
ifn
mostli
mixtur
differ
alpha
interferon
bovin
cell
line
use
assay
sensit
human
gamma
ifn
therefor
believ
ifn
yield
record
repres
alpha
ifn
valu
measur
immunoturbidometr
method
none
patient
hypogammaglobulinemia
one
patient
abnorm
high
igg
level
low
level
lga
three
patient
complement
valu
lower
borderlin
agespecif
rang
patient
similar
valu
complement
otherwis
patient
normal
level
complement
compon
differ
group
evalu
mannwhitney
utest
leukocyt
children
recurr
respiratori
infect
control
examin
interferon
product
stimul
differ
induc
interferon
yield
cultur
stimul
adeno
rhino
corona
rs
virus
mycoplasma
statist
significantli
lower
patient
cell
control
influenza
viru
show
similar
tendenc
almost
statist
signific
differ
tabl
uneven
distribut
ifn
titr
two
group
children
shown
fig
leukocyt
children
show
interferon
product
least
differ
induc
patient
control
show
detect
product
stimul
one
remain
induc
tabl
ii
furthermor
leukocyt
mani
patient
produc
interferon
yield
lower
level
control
stimul
least
one
induc
among
control
children
belong
lowproduc
group
inducerspecif
differ
patient
control
support
design
mean
ifn
produc
capac
children
estim
calcul
geometr
mean
valu
yield
differ
induc
leukocyt
children
recur
respiratori
infect
show
significantli
weaker
ifn
respons
differ
note
patient
recurr
upper
respiratori
tract
infect
patient
frequent
middl
ear
infect
patient
ongo
respiratori
tract
infect
antibiot
treatment
differ
patient
vitro
ifn
respons
differ
agent
product
interferon
influenc
neither
age
sex
children
spontan
ifn
product
detect
leukocyt
cultur
either
patient
control
reduc
virusinduc
interferont
product
leukocyt
cultur
children
suffer
recurr
respiratori
infect
report
time
ago
evid
accumul
sinc
partli
controversi
studi
shown
defect
easili
demonstr
use
differ
natur
respiratori
pathogen
induc
furthermor
defect
inducerspecif
sens
person
show
low
respons
one
induc
yet
respond
least
moder
anoth
induc
similar
variat
also
seen
healthi
children
accord
previou
report
adult
pitkiranta
et
al
defect
interferon
product
patient
demonstr
children
list
whose
leukocyt
fail
produc
detect
ifn
yield
incub
one
test
induc
ifn
level
measur
cultur
supernat
two
day
incub
shown
induc
use
result
calcul
mean
capac
ifn
product
also
lower
patient
control
select
induc
repres
part
common
respiratori
pathogen
time
possibl
judg
whether
weak
ifn
respons
repres
primari
disord
interferon
product
due
impair
leukocyt
function
secondari
underli
diseas
latter
previous
propos
puglies
et
al
found
depress
ifn
product
winter
children
suffer
recurr
infect
conclus
howev
base
observ
children
children
studi
patient
control
investig
summer
glaser
et
al
shown
studi
leukocyt
medic
student
examin
period
stress
depress
concanavalin
ainduc
gamma
interferon
product
increas
glucocorticoid
level
blood
could
theoret
affect
ifn
product
vanecek
et
al
one
could
specul
patient
lower
interferon
product
valu
due
stress
preceed
oper
howev
also
children
control
group
may
stress
vaccin
subject
venipunctur
anyhow
stress
fulli
explain
inducerspecif
differ
thu
put
stress
significantli
affect
influenza
virusinduc
interferon
product
moreov
accord
anoth
report
stress
also
improv
capac
leukocyt
produc
ifn
palmblad
et
al
patient
also
slightli
older
control
howev
known
cantel
et
age
within
rang
affect
interferon
product
tendenc
toward
correl
age
ifn
yield
seen
materi
vitro
experi
known
cell
induc
interferon
product
show
subsequ
refractori
period
fail
produc
interferon
restimul
one
could
propos
patient
refractori
period
recent
infect
ongo
infect
differ
rest
patient
interferon
product
other
also
found
acut
respiratori
infect
impair
ifn
product
leukocyt
vitro
bondestam
et
al
vanecek
et
al
crucial
point
observ
inducerspecif
lower
ifn
respons
principl
specif
could
reflect
genet
properti
might
also
account
underli
diseas
former
case
assum
low
ifn
yield
inde
role
decreas
resist
infect
individu
show
poor
ifn
respons
set
induc
might
specif
suffer
infect
caus
respect
agent
caus
agent
latter
case
one
assum
diseas
caus
secondari
chang
leukocyt
subpopul
capabl
interferon
synthesi
former
hypothesi
true
one
might
abl
diagnos
infectionpron
children
advanc
chain
infect
start
latter
altern
true
respons
return
normal
level
due
cours
chain
infect
ceas
